Tuesday, March 31, 2015

In the United States decide whether to prohibit the sales of the iPhone and iPad for patents Ericsson

In February telecom equipment maker Ericsson has filed a lawsuit against Apple for patent infringement. The relevant documents were sent to the International Trade Commission US (ITC). Today ITC expressed consent to the investigation against Apple, which could result in a ban on sales of the iPhone and iPad in the United States.

Ericsson claims that Apple infringed 41 patents. It is a technology 2G and 4G, which, as stated in the European company are critical to the functionality of "apple" technology.
"Many patents Ericsson are essential for standards 2G, 3G and 4G / LTE, others - play a decisive role in the devices Apple" - said in a statement on the Swedish company. Patents Ericsson also involved in semiconductor devices Apple, the software user interface, location services and applications, as well as the operating system iOS.
At the time, manufacturers have been negotiating licensing, but the parties to reach an agreement have failed. As a result, Ericsson calls to ban the sale of a number of Apple devices in the United States.
In Apple convinced that Ericsson is aimed at getting large cash payments as a ban on the importation of any "Apple" products to the United States - a big defeat for kupertinovtsy. This will affect competition in the US economy, on the number of jobs in the country, as well as consumers and a large number of companies, schools, state and local authorities.
Not to mention how to hurt the reputation of Apple, which will lose the opportunity to sell the iPhone in the native market for themselves.
Note that in February Apple ordered to pay a fine of $ 532.9 million for the misuse of the three patents Texas company Smartflash. We are talking about technology patents relating to the storage of personal data and payment. After winning in court "patent troll" has decided to go to court with a lawsuit again. It featured the iPhone 6, iPhone 6 Plus and iPad Air 2, which were not affected in the first trial.